B101. NEW BIOLOGICAL TREATMENTS FOR ASTHMA最新文献

筛选

英文中文

Aerosolized Toll-Like Receptor Agonists Suppress Allergic Inflammation 雾化toll样受体激动剂抑制过敏性炎症

B101. NEW BIOLOGICAL TREATMENTS FOR ASTHMA Pub Date : 2020-05-01 DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4271

D. Goldblatt, G. V. Ha, A. Fouts, S. Wali, M. Martinez-Moczygemba, D. Huston, M. Tuvim, B. Dickey, S. Evans

{"title":"Aerosolized Toll-Like Receptor Agonists Suppress Allergic Inflammation","authors":"D. Goldblatt, G. V. Ha, A. Fouts, S. Wali, M. Martinez-Moczygemba, D. Huston, M. Tuvim, B. Dickey, S. Evans","doi":"10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4271","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4271","url":null,"abstract":"\u0000 Recent studies have linked exposure to microbes and a reduction of allergic diseases. We sought to determine whether activation of innate immunity by aerosolized Toll-like receptor (TLR) agonists could attenuate the development of allergic inflammation in mice.\u0000 BALB/cJ mice were sensitized and challenged with House Dust Mite (HDM). Some mice were treated by aerosol with ligands for TLR9 (ODNm362) and TLR2/6 (Pam2CSK4) in combination (Pam2-ODN). Allergic inflammation was assessed by quantification of leukocytes in bronchoalveolar lavage fluid (BALF) and epithelial mucin content with periodic acid fluorescent Schiff stain (PAFS). Pam2-ODN-treated mice exhibited a 94% reduction in eosinophils, 90% reduction in lymphocytes, and a 44% reduction in epithelial mucin content. Lymphocyte subset analysis showed a 50% reduction in TH2 cells without a detectable change in any other TH subset. Using an alternate allergic inflammation model with Ovalbumin (OVA) Pam2-ODN-treated mice showed greater than 50% reductions in total and OVA-specific IgE serum concentrations. IgG2a concentrations, which are reduced in OVA-sensitized mice, returned to baseline with Pam2-ODN treatment.\u0000 There is a stark contrast of the efficacy in mice treated before and after sensitization that suggests Pam2-ODN may modulate the tendency of sensitization when exposed to aeroallergens. Previous studies have shown that lung epithelial cells are required for Pam2-ODN lung responses, and taken together with these new data, Pam2-ODN may reprogram airway epithelial cells to be tolerogenic to aeroallergens, but additional investigation is required to understand the precise molecular mechanism of Pam2-ODN in this context.","PeriodicalId":264920,"journal":{"name":"B101. NEW BIOLOGICAL TREATMENTS FOR ASTHMA","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121271694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0